3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
38
Melanoma
15
Neoplasm Metastasis
12
Squamous Cell Carcinoma of Head and Neck
11
Lung Neoplasms
11
Skin Neoplasms
10
Neoplasms
9
Ovarian Neoplasms
8
Recurrence
7
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Urinary Bladder Neoplasms
6
Head and Neck Neoplasms
6
Carcinoma, Basal Cell
6
Breast Neoplasms
6
Adenocarcinoma
6
Uterine Cervical Neoplasms
5
Triple Negative Breast Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Squamous Cell
5
Carcinoma, Merkel Cell
5
Carcinoma
5
Prostatic Neoplasms
4
Pancreatic Neoplasms
4
Mouth Neoplasms
4
Glioblastoma
4
Fallopian Tube Neoplasms
4
Stomach Neoplasms
3
Sarcoma
3
Mycosis Fungoides
3
Interventions
Temozolomide
6
Radiotherapy
4
Cyclophosphamide
3
TIC10 compound
2
Specimen Handling
2
Irinotecan
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Everolimus
2
Etoposide
2
Diphtheria-Tetanus Vaccine
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
lorlatinib
1
larotrectinib
1
gallium maltolate
1
fimepinostat
1
etoposide phosphate
1
dostarlimab
1
dipinacoline glutamate
1
dinutuximab
1
balstilimab
1
antineoplaston AS 2-1
1
antineoplaston A10
1
abemaciclib
1
Vaccines
1
Topotecan
1
Standard of Care
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
cemiplimab
×
1 year
×
Clear all
No trials found.